{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T09:35:34.391936+00:00","company":{"ticker":"RCEL","cik":1762303,"company_name":"AVITA Medical, Inc."},"pagination":{"limit":100,"returned":8,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"executive_change","fact_key":"561ee0a0dc","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2026-05-01T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-04-29","interim":false,"role":"Chair of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Jan Stern Reed was appointed as Chair of the Board at AVITA Medical, Inc..","evidence_excerpt":"the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-26-201662","anchor_url":"https://secwatch.observer/filing/0001193125-26-201662#claim-561ee0a0dc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm"},{"fact_type":"executive_change","fact_key":"a7fc03bf5e","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2026-05-01T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-04-30","interim":false,"role":"President and Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Cary Vance was appointed as President and Chief Executive Officer at AVITA Medical, Inc..","evidence_excerpt":"the Board of Directors (the “Board”) of AVITA Medical, Inc (the \"Company\") appointed Cary Vance as President and Chief Executive Officer (\"CEO\"), effective April 30, 2026","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-26-201662","anchor_url":"https://secwatch.observer/filing/0001193125-26-201662#claim-a7fc03bf5e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm"},{"fact_type":"material_agreement","fact_key":"b58b3589e4c2f01a166740b69651e907bcb19509","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2026-01-13T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Existing Credit Agreement","agreement_type":"credit_facility","counterparty":"Lender under existing facility","effective_date":"2026-01-13","item_codes_triggered":["1.02"],"value_text":null},"claim":"AVITA Medical, Inc. terminated Existing Credit Agreement with Lender under existing facility (effective 2026-01-13).","evidence_excerpt":"Simultaneously with the closing of the Initial Commitment Amount, the Company repaid in full and terminated all of its obligations and commitments (the “Refinancing Transaction”) under the Existing Credit Agreement (as defined below).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-011167","anchor_url":"https://secwatch.observer/filing/0001193125-26-011167#claim-b58b3589e4c2f01a166740b69651e907bcb19509","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526011167/0001193125-26-011167-index.htm"},{"fact_type":"material_agreement","fact_key":"136f825ebef4b5d419189dfe15dceb206a878df1","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2026-01-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Credit Agreement and Guaranty","agreement_type":"credit_facility","counterparty":"Perceptive Credit Holdings V, LP","effective_date":"2026-01-13","item_codes_triggered":["1.01"],"value_text":"$60 million"},"claim":"AVITA Medical, Inc. entered into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP valued at $60 million (effective 2026-01-13).","evidence_excerpt":"On January 13, 2026 (the “Closing Date”), AVITA Medical, Inc. (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) and a Security Agreement (the “Security Agreement”), by and among the Company, as borrower, Avita Medical Americas, LLC, a wholly-owned subsidiary of the Company, as guarantor (the “Guarantor,” taken together with the Company, the “Obligors”) and Perceptive Credit Holdings V, LP as a lender and the administrative agent (the “Lender,” and the “Administrative Agent,” as applicable).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-011167","anchor_url":"https://secwatch.observer/filing/0001193125-26-011167#claim-136f825ebef4b5d419189dfe15dceb206a878df1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526011167/0001193125-26-011167-index.htm"},{"fact_type":"debt_financing","fact_key":"a3af1632db0789eafcedde9376319616dfe7a9ed","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2026-01-13T23:59:59+00:00","payload":{"counterparty":"Perceptive Credit Holdings V, LP","effective_date":"2026-01-13","event":"incurrence","instrument_type":"credit_facility","interest_rate_text":"greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either case,","item_codes_triggered":["2.03"],"maturity_text":"five-year senior secured credit facility","principal_text":"up to $60 million"},"claim":"AVITA Medical, Inc. incurred credit facility of up to $60 million with Perceptive Credit Holdings V, LP at greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either case, maturing five-year senior secured credit facility.","evidence_excerpt":"Credit Agreement provides for a five-year senior secured credit facility in an aggregate principal amount of up to $60 million","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-011167","anchor_url":"https://secwatch.observer/filing/0001193125-26-011167#claim-a3af1632db0789eafcedde9376319616dfe7a9ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312526011167/0001193125-26-011167-index.htm"},{"fact_type":"executive_change","fact_key":"bfad685cfa","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2024-07-01T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-28","interim":false,"role":"Chief Legal and Compliance Officer and Corporate Secretary","role_category":"general_counsel","successor_name":null,"successor_named":false},"claim":"Nicole Kelsey was appointed as Chief Legal and Compliance Officer and Corporate Secretary at AVITA Medical, Inc..","evidence_excerpt":"Ms. Shiroma is succeeded by Nicole Kelsey, effective immediately, who will serve as the Company’s Chief Legal and Compliance Officer and Corporate Secretary.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-079679","anchor_url":"https://secwatch.observer/filing/0000950170-24-079679#claim-bfad685cfa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000095017024079679/0000950170-24-079679-index.htm"},{"fact_type":"executive_change","fact_key":"00659f52c8","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2024-07-01T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2024-06-28","interim":false,"role":"General Counsel, Compliance Officer and Corporate Secretary","role_category":"general_counsel","successor_name":"Nicole Kelsey","successor_named":true},"claim":"Donna Shiroma retired as General Counsel, Compliance Officer and Corporate Secretary at AVITA Medical, Inc..","evidence_excerpt":"On June 28, 2024, Ms. Donna Shiroma, the Company’s General Counsel, Compliance Officer and Corporate Secretary, notified AVITA Medical, Inc. (the \"Company\") of her retirement effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-079679","anchor_url":"https://secwatch.observer/filing/0000950170-24-079679#claim-00659f52c8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000095017024079679/0000950170-24-079679-index.htm"},{"fact_type":"earnings_release","fact_key":"2e47fa4788e030c428da101883d089a073737ca6","cik":1762303,"ticker":"RCEL","company_name":"AVITA Medical, Inc.","filed_at":"2024-05-13T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"first quarter ended March 31, 2024","report_date":"2024-05-13","result_type":"reported_results","revenue_text":null},"claim":"AVITA Medical, Inc. updated its first quarter ended March 31, 2024 guidance (lowered).","evidence_excerpt":"On May 13, 2024, AVITA Medical, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-058618","anchor_url":"https://secwatch.observer/filing/0000950170-24-058618#claim-2e47fa4788e030c428da101883d089a073737ca6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1762303/000095017024058618/0000950170-24-058618-index.htm"}]}